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Objective:
Depression affects one in four adults with type 2 diabetes (T2DM) and is associated with worsened diabetes complications, increased health
care costs and early mortality. Rural and low-income urban areas, including the Appalachian region, represent an epicenter of the T2DM epidemic.
Program ACTIVE II is a comparative effectiveness treatment trial designed to test whether a combination of cognitive behavioral therapy (CBT)
and community-based exercise (EXER) will offer greater improvements in diabetes and depression outcomes compared to individual treatment
approaches and usual care (UC). The secondary aims are to assess changes in cardiovascular risk factors across groups and to conduct a costeffectiveness analysis of predicted incidence of cardiovascular complications across groups.

Methods:
The study is a 2-by-2 factorial randomized controlled trial consisting of 4 treatment groups: CBT alone, EXER alone, combination of CBT and
EXER, and UC. Adults with T2DM for > 1 year and who meet DSM-IVTR criteria for Major Depressive Disorder (MDD) are eligible to participate at
two rural Appalachian sites (southeastern Ohio and West Virginia) and one urban site (Indianapolis). This type II behavioral translation study uses
a community-engaged research (CEnR) approach by incorporating community fitness centers and mental health practices as interventionists.

Conclusions:
This is the first study to evaluate the comparative effectiveness of combined CBT and exercise in the treatment of depression using
community-based intervention delivery. This approach may serve as a national model for expanding depression treatment for patients with
T2DM.

Introduction
Nearly one in 10 Americans has diabetes and current projections
estimate diabetes will affect one in three Americans born in the year 2000
[1] resulting in annual T2DM-related costs of $256 billion [2]. Lowincome urban and rural areas such as the Appalachian region bear a
disproportionate burden of the national T2DM epidemic [3]. In West
Virginia (WV), the statewide age-adjustment prevalence of diagnosed
T2DM is 10.4% [4] while the average prevalence rate of T2DM in rural
Appalachian Ohio (OH) counties is 11.3% [5] exceeding the national
average of 9.3% [1]. The Appalachian region also bears a disproportionate
burden of major depressive disorder (MDD; 8.2%) compared to nonAppalachian areas (7.6%), with higher rates found in central Appalachian
states (10.6%) such as WV and OH than northern or southern states [6].
Barriers to care for T2DM and MDD in low-income urban and
rural areas such as central Appalachia are considerable and similar.
Decreased access to health and mental health care providers, lack of
public transportation and rising costs for private transportation (e.g. gas
prices) in the context of geographic isolation pose significant barriers to
consistent and effective health and mental health care [7-8].
Patients with T2DM have been found to be two times more likely to

experience depressive symptoms than their non-diabetic peers with one
in four patients reporting clinically significant depressive symptoms and
11.4% meeting criteria for MDD [9].
Depressive symptoms have been shown to be associated with worsened
blood glucose levels [10] and T2DM complications [11]. In addition,
significant functional and financial costs are associated with depression
and T2DM including decreased adherence to diabetes care regimens[12],
increased functional disability [13], increased health care costs without
resulting improvements in depression or diabetes outcomes [14],
decreased quality of life [15-16]and earlier mortality attributable to all
causes (17-18).
Few controlled treatment trials have been conducted to treat depression
and T2DM [19-23]. Only three have evaluated behavioral treatment
strategies in this population. In a meta-analysis of 29 randomized
controlled trials evaluating cognitive behavioral therapy (CBT) treatment
for MDD across a continuum of disease states, a robust effect size (-.83)
documented the efficacy of this approach [24]. In a study of 51 patients
(mean age 53 + 10 years; 60% female) diagnosed with T2DM (mean duration
8 years) and MDD randomly assigned to a 10-week individualized CBT or
control condition without medication intervention, Lustman found that
patients receiving CBT were 3 times more likely to experience depression
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remission at post-treatment assessment than controls [19]. Although no
group differences in A1c levels were found at post-treatment assessment
(adjusted for baseline values), patients in the CBT condition showed
improvement in A1c at the 6-month follow-up assessment compared to
controls [19]. Treatment responsiveness appeared to be associated with
severity of depression and A1c at baseline [19,25].

Open Access
design and methodology of this large-scale multi-site trial.

Research Design and Methods

In the Pathways Study, problem-solving therapy (a variation of CBT)
was integrated within the primary care setting to treat depression in adults
with T2DM [23]. Participants randomized to a stepped-care problemsolving therapy intervention reported higher levels of treatment exposure,
satisfaction with care and improved depression outcomes compared to
patients in the usual care group. In this study, improvements in glycemic
control were not observed immediately following care or at 6- or 12-month
follow-up assessments [23].Taken together; these studies demonstrate the
efficacy of CBT in treating depression in adults with T2DMwith mixed
results associated with changes in glycemic control.

Program ACTIVE II is a 2-by-2 factorial repeated measures RCT
design. The study is a multi-center trial in 3 states designed to maximize
generalizability of the findings across high risk groups in both urban and
rural areas to assess outcomes and to build the infrastructure necessary to
achieve a sustainable program. Program ACTIVE II uses a communityengaged research (CEnR) approach in which community organizations
are engaged in all aspects of the study: recruitment, intervention
implementation, and dissemination of findings. This approach confers
additional validity to the study outcomes by examining the effectiveness
of the intervention in the sites where they are ultimately designed to take
place and demonstrated stakeholder commitment to the intervention
which serves as a foundation for the ultimate adoption of the Program
ACTIVE intervention beyond the period of federal funding.

Exercise has the potential to directly improve glycemic outcomes in
the context of MDD treatment and has been shown to be an efficacious
treatment for clinical depression among adults without T2DM [26-27].
In a meta-analysis of 37 exercise intervention trials in clinically depressed
samples, Craft & Landers [28]found a large overall effect size (-.72) in the
reduction of clinical depression with the greatest impact found in samples
with moderate-to-severe levels of depression. Exercise interventions of 9
to12 weeks showed significantly greater impact on depression outcomes,
but no differences were observed in the types of exercise used in treatment
protocols. Exercise interventions have also been shown to improve
glycemic control in patients with T2DM [29-34].

The purpose of Program ACTIVE II is to address two primary aims:
1) to compare changes in glycemic control across individual intervention
groups to usual care (UC) at post-intervention (POST) and 6- and
12-month follow-up assessments; and 2) to compare changes in MDD
outcomes across individual intervention groups to UCat POST and 6and 12-month follow-up assessments. The study will also address two
secondary aims: 1) to compare changes in cardiovascular risk factors (e.g.
LDL cholesterol) across individual groups to UC at each of the 3 time
points; and 2) to calculate the cost-effectiveness of each treatment arm in
terms of predicted incidence of cardiovascular complications over a 10year period.

To date, only one randomized controlled trial (RCT) has examined
the impact of exercise on depression in adults with type 2 diabetes. Piette
and colleagues randomized 291 adult patients with T2DM and depressive
symptoms (mild to severe) to 12 weeks of manualized telephone-based
CBT (with 9 monthly booster sessions) with a walking programor
enhanced UC [35]. At 12-month follow-up, 58% of participants in the
intervention group had depressive symptoms fall below the mild threshold.
Number of steps was higher and systolic blood pressure was lower in
the intervention group at follow-up. No changes were observed in A1c
at the 12-month follow-up assessment [35]. The telephone-based CBT
and walking interventions were combined and could not be evaluated for
depression and A1c outcomes separately.

Sample size

To date, the existing literature has utilized traditional randomized
controlled trials that make use of research or health care personnel to
implement the interventions. No studies have evaluated the comparative
effectiveness of CBT and exercise by implementing these interventions
with community fitness and mental health providers using a communityengaged research (CEnR) approach. The challenge for health care
providers and communities is to create depression treatment programs for
T2DM patients that will reach the largest number of people at the lowest
possible cost and burden to health care organizations. Program ACTIVE
II has been designed to create a model program of community-based
depression treatment using a CEnR design that may be disseminated
and adopted nationally. Central to this model is the assumption that
effective depression treatment requires multiple avenues of access beyond
the formal health care system and multiple approaches to depression
treatment such as CBT and exercise. Program ACTIVE II has been
designed to simultaneously achieve two overarching goals: 1) to test the
comparative effectiveness of the cognitive behavioral therapy (CBT) and
community-based exercise (EXER) to usual care (UC); and 2) to develop
a sustainable program that may be used as a scalable model for T2DM and
depression treatment for national dissemination. The research team has
partnered with community mental health providers and exercise facilities
to implement the intervention. This paper reports on the innovative

Based on our pilot study [36] and a meta-analysis by Boule et al., we
used a conservative assumption of a mean (SD) difference of 0.6% (1.4%)
in improving A1c between the UC and exercise groups at post intervention
[29].Using a sample size of 43 in each of the four treatment groups will
have 80% power to detect the main effect of exercise. However, we will
recruit 54 per group assuming a 20% dropout rate.
In estimating the sample size to detect changes in MDD outcomes,
we assumed 60% and 30% remission rates for the CBT and UC groups,
respectively, at post intervention [19]. Using a sample size of 43 in each of
the four treatment groups will have 97% power to detect the main effect
of CBT.

Randomization
A site-specific computer generated randomization list was used to
randomly assign study subjects to one of the four treatment groups.
A block size of four was used to ensure balance in number of subjects
recruited in four groups after recruiting every four subjects.

Characteristics
Inclusion/Exclusion Criteria: Inclusion criteria: age 18 or older,
ambulatory status, diagnosis of T2DM for one year duration or longer,
major depression lasting 2 weeks or longer with no evidence of psychotic
symptoms. Medical exclusion criteria include: history of diabetic
ketoacidosis (DKA), continuous insulin therapy since T2DM diagnosis,
stage 2 hypertension as defined by JNC VII, recent cardiac events (e.g.
unstable angina, diagnosed angina, PTCA, any cardiac intervention
for CAD or tachydysrhythmias in the past 6 months), laser surgery for
proliferative retinopathy in the past 6 months, history of stroke, lower
limb amputation, asensory peripheral neuropathy, aortic stenosis or other
severe valvular heart disease, atrial fibrillation, severe COPD (e.g., basal
oxygen), class III or IV heart failure or medical instability. Psychiatric
exclusion criteria include: active suicidal ideation or a history of suicide
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attempt, bipolar depression or history of psychotic disorder and current
substance abuse or dependence disorder. Participants who are currently
prescribed antidepressant medications for 6 weeks or longer and who
meet diagnostic criteria for major depression without psychotic features
are included.
Participants who report the use of a current antidepressant medication
for 5 weeks or less are excluded or deferred for later screening after the
6-week period. Participants who are currently receiving psychotherapy
from a mental health provider for MDD are excluded. Participants who
are currently receiving only medication management from a psychiatrist
are included. Respondents who meet eligibility criteria are invited to
participate in the baseline screening assessment and referred to their local
site PI.

Recruitment
Participants are recruited from communities served by the 3
intervention areas: Indianapolis, southeastern Ohio/western West Virginia
and north central West Virginia. Advertising takes place via physician
offices, newspapers, radio stations, community centers, partnering
community organizations and community events. In addition, patients of
partner medical practices are contacted by phone to receive information
about the study and to inquire about interest and eligibility (IU and WV).
The recruitment flow chart is shown in Figure 1 (below).Individuals are
screened by telephone by trained study staff to determine initial eligibility.
Once eligible via phone screen, participants are scheduled for a baseline
assessment visit where the informed consent takes place. Medical and
psychiatric data from the baseline assessment are reviewed by the study
or site medical directors (JS. FS, KF, KM), exercise physiologist (GH) and
PI (MdG) as a group to determine eligibility for study enrollment. Eligible
participants are then randomly assigned to one of the four groups: CBT,
EXER, CBT+EXER or UC.

Local advertising
IUSM phone screening
Medical assessment
Eligible

Referred to current
physician for stress test?

No approval
Ineligible
Physician
approval

Psychiatric Interview

Eligible

Deferred

Ineligible

1 of 3 Sites:
Randomization to Intervention
Figure 1: Recruitment Flow Chart
Separate randomization lists were generated by the study statistician
for use by each study site.

Assessment procedures
Psychological, behavioral and physiologic measures are administered
at each assessment period: baseline, post-intervention, 6- and 12-month
follow-up with the exception of demographic characteristics (baseline
only). Measures are shown in Table 1.
At the beginning of the baseline assessment visit, individuals are
consented to participate in the study by the Site PI or project coordinator.
Baseline assessment includes the medical history interview, blood draws,
anthropometric measurements and fitness assessment. Participants
are given a pedometer, food and activity diaries and questionnaires
to complete following the baseline assessment. Participants complete
psychosocial measures at home (returned by mail) and complete a SCID
Axis I interview by phone. The core investigator team, site PIs and
project coordinators conduct weekly teleconferences to review all data
following baseline assessment. Participants who meet all study criteria are
randomized to one of the four intervention groups, scheduled for a free
nutritional education program and their first intervention session (CBT,
EXER or CBT+EXER) the following week.

Interventions
The active interventions in Program ACTIVE II are 12-weeks of
community-based exercise and 10 individual sessions of CBT. In order to
facilitate diabetes education and to offer an incentive to UC participants,
Dining with Diabetes nutrition classes are provided to participants in
all arms. Based on prior studies, nutrition education is not expected to
influence depression outcomes [19].
CBT Intervention: CBT has gained wide acceptance as an efficacious
intervention approach for the treatment of depression [50]. CBT posits
that cognitions, emotions and behaviors are interwoven and mutually
reinforcing in the depressed patient [50]. Treatment involves the
identification and reframing of “automatic thoughts” (i.e., cognitive
biases) that work in the service of depressogenic core cognitive beliefs [50].
Cognitive biases and core beliefs are empirically tested and restructured.
Behavioral techniques, such as increasing daily activity and development
and interaction with social support networks are interwoven into CBT
therapy [50]. The use of cognitive and behavioral tools modeled in therapy
and generalized by the participant through take home activities provides
participants with an opportunity to generalize skills to situations beyond
the therapeutic relationship.
CBT sessions are conducted by trained licensed mental health providers
currently in practice in their respective communities. They represent the
range of practice environments from individual private practitioners to
community mental health centers. Participants receive 10 sessions of
CBT using the manualized approach based on Beck’s model of cognitive
therapy [50].Sessions are scheduled weekly over the course of the 12week period. In light of the large array of skills that are possible to include
in the CBT framework, selected goals have been targeted for our brief
therapy format (presentation of CBT model; thought records, cognitive
distortions, counterarguments, cognitive reframing, automatic thoughts,
core beliefs, and relapse prevention). CBT therapists receive training in
CBT and manualized training approach from the study team.
Exercise Intervention: The exercise protocol is a community-based
exercise intervention based on the aerobic exercise goals adapted from the
Lifestyle Balance behavior arm of the DPP [44]. Partner exercise facilities
represent a range of fitness facilities including physical therapy practices,
community centers and for-profit and non-profit fitness organizations
(e.g. YMCA). Trained instructors at each facility provide 6 classes of
monitored instruction on exercise to participants to meet heart rate and
activity-level goals. Membership to the centers is provided to participants
free of cost throughout the 12-week intervention period. Passes to fitness
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Screening

Baseline

POST

6- and 12Mo. FollowUp

X
X

X

X

Lifetime
X
X
X
X

Current
X
X
X
X

Current
X
X
X
X

X
X

X
X

X
X

X
X
X

X
X
X

X
X
X

X
X
X
X
X
X
X

X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X

Outcome
Variable

Covariate

Clinical
Monitoring
Variable

Psychosocial
Demographic Characteristics
Structured Clinical Interview for the DSMIVTR (SCID Axis I Disorders)
Beck Depression Inventory (BDI)
Diabetes Quality of Life (DQOL)
SF-36 Quality of Life Measure
Chronic Illness Resource Survey (CIRS)
Behavioral
Physical Activity Diary (1 week)
Pedometer (1 week)
Physiologic
Glycated Hemoglobin (A1c)
Blood lipid profile (HDL-C; triglycerides)
Self-Monitored Blood Glucose (SMBG)
Medical History Interview
Medical Status Review
6-Minute Walk Test
Height
Weight
Waist/Hip Girth
Blood Pressure
Resting Heart Rate/Pulse
Perceived Exertion (Borg rating)

X (Screener)

X

X
Primary
Primary
Secondary
Secondary
Secondary
X
X
Primary
Secondary
X
X
X

Secondary
X
X
Secondary

X
X
X

Table 1: Administration of Assessment Measures in Program ACTIVE

facilities and costs for time spent with the fitness trainer are purchased by
the grant to increase access to exercise for the duration of the protocol.
These costs replicate costs of the program to community members of an
independent program.
Exercise goals are adapted to accommodate the physical and medical
restrictions of an older-adult T2DM population. Exercise prescriptions
are based on the results obtained from the baseline 6MWT. Participants
are given exercise goals of performing 150 minutes per week of moderate
activity at 40- <60% of heart rate reserve (HRR), comparable to a Rating
of Perceived Exertion of 11-13. These goals may be modified based on
results of the 6 Minute Walk Test (6MWT). Due to high rates of sedentary
behaviors in this population, physical activity goals are increased in a
graduated fashion during Weeks 1-3, beginning with 100 minutes of
weekly aerobic exercise to 150 minutes of total aerobic weekly exercise
by Weeks 4-12 [47]. Intensity of activity begins at 40% in Week 1 and
progresses as tolerated, but continues to remain below 60% of HRR.
In order to provide participants with the necessary training to begin
a safe exercise program, exercise classes are taught by trained fitness
instructors at each exercise site in Weeks 1-4 and again in Weeks 6 and 8. In
Week 1, participants are introduced to the proper use of exercise equipment
and the exercise prescriptions. During these sessions, participants are
monitored for 50-minutes of exercise by the exercise fitness instructor.
Participants are trained to exercise in a manner consistent with ACSM
recommendations including 10 minutes of pre-activity (warm-up and
stretching), 30 minutes of active exercise (endurance), and 10 minutes of
post-activity (cool down, recovery) [47,51]. Participants receive feedback
throughout the 50-minute session on their intensity for each given activity.
Heart rate and blood pressure are measured at rest, at peak activity level,
and following recovery. Participants are trained to utilize the Borg Scale
[52] during their activity to monitor exercise intensity.
In Weeks 2-4, participants are given personalized instruction on

exercise modes available including walking on a track, use of treadmills and
stationary recumbent/ upright ergometers consistent with the equipment
of each fitness location. In weeks 6 and 8, participants attend an in-person
booster session at their local exercise center to re-establish the appropriate
exercise intensity and assess exercise technique. Exercise prescriptions
may be adjusted at this time based on the information obtained about
exercise intensity. At each class, a chapter from the Program ACTIVE
II Exercise Manual is provided to participants. Adapted from the DPP
Lifestyle Balance intervention materials, the manual is designed to
address psychological barriers associated with physical activity (e.g. social
support, motivation, behavioral goals).
Participants are asked to complete weekly exercise diaries and to record
number of steps measured using pedometers provided by the study (Weeks
1-12) on paper or in electronic form through the website. Participants are
contacted bi-weekly by a member of the study team to review information
from activity diaries and pedometers and to evaluate any exercise-related
medical concerns including: hyperglycemia, hypoglycemia, joint pain,
back pain, angina, lightheadedness, and symptoms of hypotension. Data
from participants who report medical symptoms resulting from exercise
will be shared with the Medical Director for the respective site. The
development of severe adverse events is communicated to the site Medical
Director, Data Safety and Monitoring Panel and hosting IRB offices
for consultation. SMBG data is downloaded electronically to examine
significant changes in daily blood sugars as a result of exercise. Participants
who show increased instances of hyper- or hypoglycemia are contacted by
the project coordinator and advised to contact their primary care provider
for assessment of medications. Participants are provided with electronic
(via website) and paper (as needed) supplemental adherence materials
(i.e. toolkit) such as walking maps, self-care information, and games to
promote adherence.
Nutrition Intervention: In order to evaluate the effectiveness of the
target interventions in the context of T2DM treatment best practices,
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participants in all 4 groups are provided classes in the Dining with
Diabetes (DWD) program through The Ohio State University, West
Virginia University Extension or Purdue University Marion County
Extension.

with Dr. Chandan Saha of the IUSM Department of Biostatistics. The
Core Investigators meet monthly by phone to discuss issues related to
recruitment, implementation of the intervention, participant safety, and
to monitor data trends (e.g., adherence, missing data.

Statistical analyses

Conclusions

The intention-to-treat principle will be used for all analyses.
Differences in participants’ baseline characteristics among 4 groups will
be evaluated by ANOVA or the nonparametric Kruskal-Wallis test for
continuous outcomes and by Chi-square test for categorical outcomes. A
mixed-model analysis of variance including site, treatment group, time,
gender, race, age, baseline value of A1c will be used to assess the effects of
exercise on A1c at post-intervention, 6- and 12-month. Participants will
be treated as a random effect and a un-structure covariance matrix will be
used. The dichotomous primary outcome, remission in depression, will be
analyzed by a non-linear mixed-effects model and will adjust for potential
confounder’s gender, race, age and baseline depression score. In each of
the above two models, an interaction effect between time and treatment
group will be assessed first. If there is no interaction effect, the overall
treatment difference will be assessed. Otherwise, treatment difference
will be assessed at each time point. The model will be fitted by the SAS
procedure NLMIXED.

T2DM and co-morbid depression represents a growing challenge to
patients and health care systems as the prevalence of both disorders rises
but access to treatment remains limited. In this study, we are investigating
the comparative effectiveness of a combination of CBT and exercise using
a CErN approach in which community fitness and mental health partners
provide depression treatment to study participants. This approach is novel
because it is the first study to examine the comparative effectiveness of two
behavioral treatment approaches to depression and T2DM. Moreover, it
leverages community resources such as fitness centers, community centers
and community mental health professionals that already exist in rural and
low-income urban communities to serve as treatment partners to health
care centers. At the same time, it expands knowledge of diabetes treatment
issues to these community providers thereby expanding continuity of care
for participants.

Secondary Outcomes
Functional exercise status and cardiovascular risk factors: A
repeated measures ANCOVA will be conducted to assess changes in
highest HR during the 6 minute walk test, distance achieved, LDL-C,
HDL-C, triglycerides, and resting blood pressure from baseline to POST
and baseline to the 6- and 12-month assessments.
Cost-effectiveness (CE) analyses: A Markov decision model of type
2 diabetes progression to complications will be constructed using cost
data collected at baseline, post-intervention, 6 and 12 months of followup. Short- and long-term effects of the intervention can be estimated by
including time horizons 3, 10, 20 and lifetime in the Markov model. All
costs will be adjusted to the year 2007 using the US Consumer Price Index.
Markov models: We will develop a Markov decision model with
sensitivity analyses to estimate the Incremental Cost-Effectiveness ratio
(ICER) of the intervention compared to UC as implemented in Program
ACTIVE II. An ICER is computed by the ratio of ΔC/ΔE where ΔC
represents the change in cost due to the intervention compared with UC
and ΔE represents the change in health benefits due to the intervention
compared with UC. We will use TreeAge Pro Suite 2009 software (TreeAge
Software, Williamstown, MA). The model will directly incorporate
intervention effectiveness and cost data as well as event probabilities from
the RCT to estimate life expectancy, quality-adjusted life-expectancy
(expressed as QALYs), clinical outcomes (diabetes complications), and
direct medical and nonmedical costs associated with the interventions
and UC.

Data Safety and Monitoring Panel
A Data Safety and Monitoring Panel (DSMP) were created to provide
expert consultation in the primary disciplines involved in the content
of the study: psychology, medicine, and exercise physiology. These
consultants provide input on issues such as metabolic or physiological
changes in participants during participation, mental status of participants,
and implementation of the exercise protocol throughout Program
ACTIVE II. Members of the panel are available for consultation for issues
of research ethics, clinical care, and human subject’s protection. Members
of the panel are independent from the research team to ensure objectivity
in the treatment of participants.
Data integrity is reviewed by the Core Investigators in consultation

Data from this study will provide the empirical foundation for
community stakeholders to evaluate the value of this program in terms
of health and mental health outcomes in their communities and to
identify the ways that this may become a sustainable treatment resource
for communities beyond the period of federal funding. Lessons learned
from this study will also inform the dissemination of this intervention as a
model that may be scaled to the national level to alleviate the burden and
costs with this important set of disorders.
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